Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members

Astrid G. S. van Halteren, Ewa Jankowska-Gan, Antoinette Joosten, Els Blokland, Jos Pool, Anneke Brand, William J. Burlingham, Els Goulmy

Blood (2009) 114 (11): 2263–2272.

https://doi.org/10.1182/blood-2009-01-200410

Published: 2009

Journal Articles

Hypomethylating drugs convert HA-1–negative solid tumors into targets for stem cell–based immunotherapy

Lothar Hambach, Kam-Wing Ling, Jos Pool, Zohara Aghai, Els Blokland, Hans J. Tanke, Jan A. Bruijn, Hans Halfwerk, Hester van Boven, Brigitte Wieles, Els Goulmy

Blood (2009) 113 (12): 2715–2722.

https://doi.org/10.1182/blood-2008-05-158956

Published: 2009

Includes: Supplemental data

Journal Articles

Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen–specific cytotoxic T lymphocytes

Liesbeth E. M. Oosten, Els Blokland, Astrid G. S. van Halteren, Julie Curtsinger, Matthew F. Mescher, J. H. Frederik Falkenburg, Tuna Mutis, Els Goulmy

Blood (2004) 104 (1): 224–226.

https://doi.org/10.1182/blood-2003-07-2461

Published: 2004

Includes: Supplemental data

Journal Articles

The minor histocompatibility antigen HA-3 arises from differential proteasome–mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

Eric Spierings, Anthony G. Brickner, Jennifer A. Caldwell, Suzanne Zegveld, Nia Tatsis, Els Blokland, Jos Pool, Richard A. Pierce, Sahana Mollah, Jeffrey Shabanowitz, Laurence C. Eisenlohr, Peter Van Veelen, Ferry Ossendorp, Donald F. Hunt, Els Goulmy, Victor H. Engelhard

Blood (2003) 102 (2): 621–629.

https://doi.org/10.1182/blood-2003-01-0260

Published: 2003

Journal Articles

Generation of minor histocompatibility antigen HA-1–specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

Tuna Mutis, Els Blokland, Michel Kester, Ellen Schrama, Els Goulmy

Blood (2002) 100 (2): 547–552.

https://doi.org/10.1182/blood-2002-01-0024

Published: 2002

Journal Articles

General T-cell receptor antagonists to immunomodulate HLA-A2–restricted minor histocompatibility antigen HA-1–specific T-cell responses

Joke M. M. den Haan, Tuna Mutis, Els Blokland, Ad P. IJzerman, Els Goulmy

Blood (2002) 99 (3): 985–992.

https://doi.org/10.1182/blood.V99.3.985

Published: 2002

Journal Articles

UTY gene codes for an HLA-B60–restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition

Mario H. J. Vogt, Els Goulmy, Freke M. Kloosterboer, Els Blokland, Roel A. de Paus, Roel Willemze, J. H. Frederik Falkenburg

Blood (2000) 96 (9): 3126–3132.

https://doi.org/10.1182/blood.V96.9.3126

Published: 2000

NARROW

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members

Hypomethylating drugs convert HA-1–negative solid tumors into targets for stem cell–based immunotherapy

Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen–specific cytotoxic T lymphocytes

The minor histocompatibility antigen HA-3 arises from differential proteasome–mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

Generation of minor histocompatibility antigen HA-1–specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

General T-cell receptor antagonists to immunomodulate HLA-A2–restricted minor histocompatibility antigen HA-1–specific T-cell responses

UTY gene codes for an HLA-B60–restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition

Email alerts

ASH Publications

American Society of Hematology

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members

Hypomethylating drugs convert HA-1–negative solid tumors into targets for stem cell–based immunotherapy

Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen–specific cytotoxic T lymphocytes

The minor histocompatibility antigen HA-3 arises from differential proteasome–mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

Generation of minor histocompatibility antigen HA-1–specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

General T-cell receptor antagonists to immunomodulate HLA-A2–restricted minor histocompatibility antigen HA-1–specific T-cell responses

UTY gene codes for an HLA-B60–restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only